ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2019

The Impact of Twice-Daily Indacaterol/Glycopyrrolate on the Components of Health-Related Quality of Life and Dyspnea in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease.

Donald A Mahler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.